1 minute read - 19th January 2023
Work starts on Upperton’s new £15m Notts facility
Upperton Pharma Solutions has begun work on its new £15m GMP* manufacturing and development headquarters in Nottingham. The ground was officially broken on the project at the beginning of January and construction work has now started in earnest to deliver the specialist contract development and manufacturing firm’s 50,000 square foot facility, which is expected to be fully operational by the end of 2023.
The new site is situated less than two miles from Upperton’s current headquarters and will provide a significant expansion of the company’s capabilities in terms of capacity and scale of manufacture with the incorporation of ten new GMP manufacturing suites, quality control laboratories and dedicated analytical and formulation development laboratories with pilot plant facilities. When fully operational, it is expected to create in the region of 150 additional full-time jobs by the end of 2024.
Nikki Whitfield, CEO of Upperton, said: “Announcing that we have broken ground on our new state-of-the-art manufacturing and development headquarters is without doubt one of the most important milestones in our company’s twenty-year history. This plant has been in the planning for almost twelve months, so to see the plans finalised and work start on the site is hugely satisfying, not only to us as a business, but also for our customers as we can now offer them a seamless transition from early development to clinical trials and commercial manufacturing, all at the one site.”
Upperton says the new site will have the capability to handle a range of dosage forms including solids, liquids, semi-solids, nasal and inhaled products, allowing it to support early formulation development, provide clinical trial supplies from phase 1 to phase 3, and niche-scale commercial manufacture. The GMP facility design, equipment procurement and containment capabilities have been aligned with larger scale process trains, supporting batch scales of up to 250kg.
*GMP (good manufacturing practice) is a system used for ensuring that pharmaceutical goods are consistently produced and controlled according to quality standards.